9Meena K,Michael M,Eric B.Social determinants of von Willebrand factor the whitehall Ⅱ study[J].Arteriosclex Thromb Vasc Biol,2000,20:1842-1847.
10Johns Y.Abnormalities of coagulation and fibrinolysis in insulin resistance:Evidence for a common antecedent[J].Am Diabetes Association,1999,22(35):25c-30c.
二级参考文献36
1Libby P,Ridker PM,Maseri A. Inflammation and atherosclerosis[J]. Circulation,2002,105:1135-1143.
2Ross R. Atherosclerosis-an inflammatory disease[J]. N Engl J Med,1999,340(2):115-126.
3Dichtl W,Nilsson L,Goncalves I,et al. Very low-density lipoprotein activates nuclear factor-κB in endothelial cells[J]. Circ Res,1999,84:1085-1094.
4Girelli D,Russo C,Ferraresi P,et al. Polymorphisms in the factor Ⅶ gene and the risk of myocardial infarction in patients with coronary artery disease[J]. N Eng1 J Med,2000,343(9):774-780.
5Kawasaki T,Kaida T,Arnout J,et al. A new animal model of thrombophilia confirms that high plasma factor Ⅷ levels are thrombogenic[J]. Thromb Haemost,1999,81:306-311.
6Cortellaro M,Boschetti C,Cofrancesco E,et al. The PLAT Study:hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients:principal results[J]. Arterioscler Thromb,1992,12:1063-1070.
7Salomaa V,Stinson V,Kark JD,et al. Association of fibrinolytic parameterswith early atherosclerosis:the ARIC study[J]. Circulation,1995,91:284-290.
8Davidson M,Kuo CC,Middaugh JP,et al. Confirmed previous infection with chlamydia pneumoniae(TWAR)and its presence in early coronary athersclerosis[J]. Circulation,1998,98(7):628-633.
9Campbell LA,Brien ER,Cappuccio AL,et al. Detection of chlamydia pneumoniae TWAR in human coronary atherectomy tissues[J]. J Infect Dis,1995,172(2):585-588.
10Krausse R,Leiendecker J,Herrmann G,et al. Chlamydia pneumoniae infection and restenosis in patients with coronary heart disease[J]. Infection,2003,31(3):149-154.
5Cruz, M.A.,J. Whitelock,,J. fei Dong.Evaluation of ADAMTS-13 activity in plasma using recombinant von Willebrand Factor A2 domain polypeptide as substrate. Thrombosis and Haemostasis . 2003
6Sakai H,Goto S,K im JY,et al.P lasm a concentration ofvon W illebrand factor in acute myocard ial infarction. Thrombosis and Haemostasis . 2000
7Chong AY,Blann AD,Lip GYH.Assessment of endothelial damage and dysfunction: observations in relation to heart failure. Quarterly Journal of Medicine . 2003
8Montalescot G,Philippe F,Ankri A,et al.Early increase of von Willebrand factor predicts adverse outcome in unstable coronary artery disease, beneficial effects of enoxaparin. Circulation . 1998
9Montalescot G,Philippe F,Ankri A,et al.Early increase of von Willebrand factor predicts adverse outcome in unstable coronary artery disease, beneficial effects of enoxaparin. Circulation . 1998
10Wiman B,Andersson T,Hallqvist J,et al.Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study. Arteriosclerosis and Thrombosis . 2000
